Your browser doesn't support javascript.
loading
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
Bharmal, Murtuza; Nolte, Sandra; Lebbé, Céleste; Mortier, Laurent; Brohl, Andrew S; Fazio, Nicola; Grob, Jean-Jacquez; Pusceddu, Sara; Hanna, Glenn J; Hassel, Jessica C; Kiecker, Felix; Ellers-Lenz, Barbara; Bajars, Marcis; Güzel, Gülseren; Nghiem, Paul; Hunger, Matthias; Schlichting, Michael; Henry-Szatkowski, Mickaël; D'Angelo, Sandra P.
Afiliação
  • Bharmal M; EMD Serono Research & Development Institute, Inc., Rockland, MA 02370, USA; a business of Merck KGaA, Darmstadt, Germany.
  • Nolte S; ICON plc, Munich, Germany/Lyon, France.
  • Lebbé C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin & Berlin Institute of Health, Berlin, Germany.
  • Mortier L; Université de Paris, INSERM U976 & Dermatology & CIC, AP-HP, Saint Louis Hospital, Paris, France.
  • Brohl AS; Department of Dermatology, CARADERM and University of Lille, Inserm U1189, CHU Lille, Lille Cedex, France.
  • Fazio N; Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Grob JJ; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
  • Pusceddu S; Aix-Marseille University, AP-HM Hospital, Marseille, France.
  • Hanna GJ; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Hassel JC; Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Kiecker F; Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Ellers-Lenz B; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin & Berlin Institute of Health, Berlin, Germany.
  • Bajars M; Merck KGaA, Darmstadt, Germany.
  • Güzel G; EMD Serono Research & Development Institute, Inc., Billerica, MA 01821, USA; a business of Merck KGaA, Darmstadt, Germany.
  • Nghiem P; Merck KGaA, Darmstadt, Germany.
  • Hunger M; Division of Dermatology, University of Washington Medical Center at South Lake Union, Seattle, WA 98109, USA.
  • Schlichting M; ICON plc, Munich, Germany/Lyon, France.
  • Henry-Szatkowski M; Merck KGaA, Darmstadt, Germany.
  • D'Angelo SP; ICON plc, Munich, Germany/Lyon, France.
Future Oncol ; 16(27): 2089-2099, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32938212
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Carcinoma de Célula de Merkel / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Carcinoma de Célula de Merkel / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2020 Tipo de documento: Article